Psychoactive Class
Stimulant
Receptor Profile
Receptor Actions
Other
Metabolizes into DMAE and pCPA
DMAE is converted to choline which serves as a precursor for acetylcholine synthesis
inhibits acetylcholinesterase
inhibits MAO-A and MAO-B (in vitro)
Effect Profile
Curated + 1 Reports
Stimulant
5.5
Moderate stimulation and focus with mild anxiety/jitters, low euphoria
Stimulation / Energy×3
7
Euphoria / Mood Lift×2
2
Focus / Productivity×2
7
Anxiety / Jitters×1
5
Based on reports from:
Tolerance & Pharmacokinetics
drugs.wikiTolerance Decay
Full tolerance
1d
Half tolerance
10d
Baseline
~18d
Experience Report Analysis
Erowid
1
Reports
2000–2000
Date Range
Demographics
Gender Distribution
Reports Over Time
References
Cited References
- Alzheimer's Drug Discovery Foundation: Centrophenoxine Review
- Erowid: Meclofenoxate Vault
- Hochschild 1973: Effect on lifespan in mice
- Malík & Tlustoš 2022: Nootropics as Cognitive Enhancers
- Meclofenoxate DrugBank Entry
- Nootropics Expert: Centrophenoxine
- Stancheva & Alova: MAO inhibition study
- USADA: Meclofenoxate Information
- Vinmec: Uses of Lucimax
- SelfHacked: Centrophenoxine Guide